Table 2 Baseline demographic, Tanita, and cardiovascular characteristics of the study participants.

From: A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress

Variable

Total study sample (n = 100)

Study group (n = 50)

Control group (n = 50)

p value

Age, mean (SD), years

73.1 (7.5)

71.9 (7.2)

74.2 (7.7)

0.126

Sex

0.414

 Male, n (%)

40 (40.0)

18 (36.0)

22 (44.0)

 

 Female, n (%)

60 (60.0)

32 (64.0)

28 (56.0)

 

Education, mean (SD), years

10.0 (4.2)

10.5 (4.2)

9.5 (4.3)

0.242

Years from MCI diagnosis, mean (SD)

3.1 (3.0)

2.8 (2.8)

3.3 (3.1)

0.399

Family history of cognitive impairment, n (%)

46 (46.0)

22 (44.0)

24 (48.0)

0.688

Body composition (Tanita) (SD)

 Fat mass (%)

35.2 (9.2)

35.6 (7.9)

34.9 (12.4)

0.737

 Body water (%)

45.0 (5.4)

45.2 (3.8)

44.9 (11.0)

0.904

 Muscular mass (%)

14.3 (3.5)

14.0 (3.6)

14.5 (4.5)

0.166

 Bone mass (%)

3.3 (0.4)

3.3 (0.3)

3.2 (0.8)

0.411

Cardiovascular risk, mean (SD)

 Blood pressure, mmHg

  Systolic

136.9 (17.2)

134.9 (18.0)

138.9 (16.4)

0.248

  Diastolic

79.8 (10.1)

79.4 (11.2)

80.1 (9.1)

0.732

 Heart rate, bpm

66.7 (11.0)

66.4 (10.2)

66.9 (11.8)

0.821

 Weight, kg

72.0 (13.2)

71.4 (11.7)

72.6 (17.8)

0.691

 BMI, kg/m2

28.2 (4.9)

28.1 (3.7)

28.3 (7.1)

0.860

 Diabetes, n (%)

16 (16.0)

4 (8.0)

12 (24.0)

0.054

 Hypercholesterolemia, n (%)

56 (56.0)

32 (64.0)

24 (48.0)

0.107

 Hypertension, n (%)

69 (69.0)

35 (70.0)

34 (68.0)

0.829

 Smokers, n (%)

16 (16.0)

6 (12.0)

10 (20.0)

0.275

  1. SD standard deviation.